Contineum Therapeutics, Inc. (CTNM) Insider Trading

Name: Contineum Therapeutics, Inc. (CTNM) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 8, 2026): Stengone Carmine N. (CEO and President): Exercise/Conversion of 2,500 shares, $2.5K.

Get alerted when insiders trade CTNM

Email address

Loading company data...

Loading company details...